Integene International LLC
Platform technology unique patented gene therapy treatments for peripheral artery disease (CLI) , ischemic heart disease .
Biotech. Unique platform technology for treatments of vascular diseases. Engineered Gene Therapy and Stem Cell Therapy creates directional angiogenesis. Very strong preclinical data. Peripheral Artery Disease (PAD). T2 diabetes epidemic causes critical lower limb ischemia (CLI) 200,000 gangrenous amputations in US. annually. GenstemX Therapy potential cure. 60% of all patients with T2 globally will get this disease. NO pharmacological cure.